This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Nov;1(8):1095-7.

doi: 10.1001/jamaoncol.2015.2733.

Chemotherapy--A Viable Partner for Cancer Immunotherapy?

Leisha A Emens¹

Affiliations

PMID: 26291503
DOI: 10.1001/jamaoncol.2015.2733

Comment

Chemotherapy--A Viable Partner for Cancer Immunotherapy?

Leisha A Emens. JAMA Oncol. 2015 Nov.

. 2015 Nov;1(8):1095-7.

doi: 10.1001/jamaoncol.2015.2733.

Author

Leisha A Emens¹

Affiliation

¹ Kimmel Cancer Center at Johns Hopkins, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

PMID: 26291503
DOI: 10.1001/jamaoncol.2015.2733

No abstract available

PubMed Disclaimer

Comment on

Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
Heery CR, Ibrahim NK, Arlen PM, Mohebtash M, Murray JL, Koenig K, Madan RA, McMahon S, Marté JL, Steinberg SM, Donahue RN, Grenga I, Jochems C, Farsaci B, Folio LR, Schlom J, Gulley JL. Heery CR, et al. JAMA Oncol. 2015 Nov;1(8):1087-95. doi: 10.1001/jamaoncol.2015.2736. JAMA Oncol. 2015. PMID: 26291768 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information